Matches in Wikidata for { <http://www.wikidata.org/entity/Q91506021> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- Q91506021 description "article scientifique publié en 2019" @default.
- Q91506021 description "artículu científicu espublizáu en mayu de 2019" @default.
- Q91506021 description "scientific article published on 08 May 2019" @default.
- Q91506021 description "wetenschappelijk artikel" @default.
- Q91506021 description "наукова стаття, опублікована 8 травня 2019" @default.
- Q91506021 name "Pharmacokinetics-Driven Optimization of 4(3 H)-Pyrimidinones as Phosphodiesterase Type 5 Inhibitors Leading to TPN171, a Clinical Candidate for the Treatment of Pulmonary Arterial Hypertension" @default.
- Q91506021 name "Pharmacokinetics-Driven Optimization of 4(3 H)-Pyrimidinones as Phosphodiesterase Type 5 Inhibitors Leading to TPN171, a Clinical Candidate for the Treatment of Pulmonary Arterial Hypertension" @default.
- Q91506021 type Item @default.
- Q91506021 label "Pharmacokinetics-Driven Optimization of 4(3 H)-Pyrimidinones as Phosphodiesterase Type 5 Inhibitors Leading to TPN171, a Clinical Candidate for the Treatment of Pulmonary Arterial Hypertension" @default.
- Q91506021 label "Pharmacokinetics-Driven Optimization of 4(3 H)-Pyrimidinones as Phosphodiesterase Type 5 Inhibitors Leading to TPN171, a Clinical Candidate for the Treatment of Pulmonary Arterial Hypertension" @default.
- Q91506021 prefLabel "Pharmacokinetics-Driven Optimization of 4(3 H)-Pyrimidinones as Phosphodiesterase Type 5 Inhibitors Leading to TPN171, a Clinical Candidate for the Treatment of Pulmonary Arterial Hypertension" @default.
- Q91506021 prefLabel "Pharmacokinetics-Driven Optimization of 4(3 H)-Pyrimidinones as Phosphodiesterase Type 5 Inhibitors Leading to TPN171, a Clinical Candidate for the Treatment of Pulmonary Arterial Hypertension" @default.
- Q91506021 P1433 Q91506021-26AA8AFC-71FA-4E23-AE0C-946D0406125C @default.
- Q91506021 P1476 Q91506021-DB358C65-2FC5-4056-81F7-EC721F0604D3 @default.
- Q91506021 P2093 Q91506021-226BD875-7B63-47C4-B53C-2CCE34CDF0AF @default.
- Q91506021 P2093 Q91506021-2C11B959-7E7A-4059-BF18-4E4EF17E9C79 @default.
- Q91506021 P2093 Q91506021-42FE80F4-AA58-4531-9357-CD00650D4110 @default.
- Q91506021 P2093 Q91506021-5042B3BA-6A17-49DE-8362-C8801E117BC8 @default.
- Q91506021 P2093 Q91506021-6503CF5E-0825-4D85-BC23-91D16B8856C2 @default.
- Q91506021 P2093 Q91506021-7EDDCDBD-C8A8-46D2-9B43-F6EC801ECAB0 @default.
- Q91506021 P2093 Q91506021-87E14227-7517-4D14-930A-BB20CA14960E @default.
- Q91506021 P2093 Q91506021-8F3D4EB4-C2F4-4D8A-836C-15A2D77E5BE9 @default.
- Q91506021 P2093 Q91506021-97E56749-02A6-4FF5-9F1A-B3742EE0856F @default.
- Q91506021 P2093 Q91506021-B307E91C-4C75-4B91-A3F9-90053947360D @default.
- Q91506021 P2093 Q91506021-BC4AEC00-B537-4E81-B9D4-6C207B9C4657 @default.
- Q91506021 P2093 Q91506021-CBD96D71-AC6C-4C38-81A7-F0572F60E2BB @default.
- Q91506021 P2093 Q91506021-D97651C9-8CD9-42D1-A7A9-70C14C8AE958 @default.
- Q91506021 P2093 Q91506021-DFB29DEF-16F1-42BA-BB46-18F6E8B83F85 @default.
- Q91506021 P2093 Q91506021-E0A2BD93-D81C-49A7-925C-76E3ABEC5797 @default.
- Q91506021 P2093 Q91506021-F712C188-5DD0-47EE-ABF2-BA5C05B78B87 @default.
- Q91506021 P2093 Q91506021-FA7CA2AB-7A93-495D-A8A3-ECBD16998A66 @default.
- Q91506021 P2860 Q91506021-646E25A9-EA2C-4338-8883-E92F3A322AE2 @default.
- Q91506021 P304 Q91506021-34F955FA-3F6E-4863-B112-26EB716613CD @default.
- Q91506021 P31 Q91506021-0FD8F4A0-58F3-4F7F-8D56-9836AB2D2803 @default.
- Q91506021 P356 Q91506021-E18CA2ED-F113-45F4-BBD2-4C000E90E9D2 @default.
- Q91506021 P433 Q91506021-CAF1A0B6-559B-47F6-A32F-7AFF8DD6D909 @default.
- Q91506021 P478 Q91506021-A28EA7EC-8C63-4589-80D6-C03CA4D58C7E @default.
- Q91506021 P50 Q91506021-03BBFFF4-CA36-48D5-A692-9727FB1B5755 @default.
- Q91506021 P50 Q91506021-51B11EF1-04AB-42F3-9139-77DFE1046611 @default.
- Q91506021 P50 Q91506021-51C470DF-5AD0-4573-A2EE-009D0B59F9FD @default.
- Q91506021 P50 Q91506021-67DA9E4E-7226-4663-89BD-809899DE4AF0 @default.
- Q91506021 P50 Q91506021-6FCC6AD3-5EF9-4CB7-B154-D69239D5EE0A @default.
- Q91506021 P50 Q91506021-7B72DB0B-4997-450A-A542-F6DE855E1B1C @default.
- Q91506021 P577 Q91506021-29F9879D-3B0F-4761-9A02-C84F0F26CF14 @default.
- Q91506021 P698 Q91506021-EAA69D2A-DC21-4A8E-B640-499C4AB2EF21 @default.
- Q91506021 P356 ACS.JMEDCHEM.9B00123 @default.
- Q91506021 P698 31021628 @default.
- Q91506021 P1433 Q900316 @default.
- Q91506021 P1476 "Pharmacokinetics-Driven Optimization of 4(3 H)-Pyrimidinones as Phosphodiesterase Type 5 Inhibitors Leading to TPN171, a Clinical Candidate for the Treatment of Pulmonary Arterial Hypertension" @default.
- Q91506021 P2093 "Chunhui Wu" @default.
- Q91506021 P2093 "Guanghui Tian" @default.
- Q91506021 P2093 "Hualiang Jiang" @default.
- Q91506021 P2093 "Jianfeng Li" @default.
- Q91506021 P2093 "Jianzhong Wu" @default.
- Q91506021 P2093 "Jin Suo" @default.
- Q91506021 P2093 "Jing Shi" @default.
- Q91506021 P2093 "Rongxia Zhang" @default.
- Q91506021 P2093 "Rulei Yang" @default.
- Q91506021 P2093 "Xianglei Zhang" @default.
- Q91506021 P2093 "Xiangrui Jiang" @default.
- Q91506021 P2093 "Xiaojun Yang" @default.
- Q91506021 P2093 "Xiaoli Zou" @default.
- Q91506021 P2093 "Xudong Gong" @default.
- Q91506021 P2093 "Yang He" @default.
- Q91506021 P2093 "Yu Wang" @default.
- Q91506021 P2093 "Zheng Liu" @default.
- Q91506021 P2860 Q27861044 @default.
- Q91506021 P304 "4979-4990" @default.
- Q91506021 P31 Q13442814 @default.
- Q91506021 P356 "10.1021/ACS.JMEDCHEM.9B00123" @default.
- Q91506021 P433 "10" @default.
- Q91506021 P478 "62" @default.
- Q91506021 P50 Q48052301 @default.
- Q91506021 P50 Q55232576 @default.
- Q91506021 P50 Q88372626 @default.
- Q91506021 P50 Q88531119 @default.
- Q91506021 P50 Q91506012 @default.
- Q91506021 P50 Q91506017 @default.
- Q91506021 P577 "2019-05-08T00:00:00Z" @default.
- Q91506021 P698 "31021628" @default.